133
Participants
Start Date
May 31, 2010
Primary Completion Date
December 31, 2012
Study Completion Date
February 28, 2013
PCI-32765
420 mg daily or 840 mg daily
New York Presbyterian Hosptial Cornell Med Center, New York
Sarah Cannon, Nashville
The Ohio State University, Columbus
Texas Oncology - Tyler, Tyler
MD Anderson Cancer Center, Houston
Stanford University School of Medicine, Stanford
Willamette Valley Cancer Institute and Research Center, Springfield
Northwest Cancer Specialists, P.C., Vancouver
Yakima Valley Memorial, Yakima
University of Vermont and Fletcher Allen Health Care, Burlington
Lead Sponsor
Pharmacyclics LLC.
INDUSTRY